2024 Europe Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts--AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis

August 2024 | - | ID: 2D58E60198E1EN
Venture Planning Group

US$ 7,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from LeadingMarketResearch.com contains analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report presents detailed analysis of the STD market in the France, Germany, Italy, Spain, and UK. Current scientific views on epidemiology and etiology are presented for:AIDS/HIV
Chancroid
Chlamydia
Gonorrhea
Granuloma Inguinale
Herpes I/II
Lymphogranuloma
Mycoplasma
Papillomavirus
Syphilis
Trichomonas VaginalisThe report provides test volume and sales forecasts by country and market segment, including:%li%Hospitals%li%Commercial/Private Labs%li%Public Health LabsIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country. Also, the report examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies%li%Reviews features and operating characteristics of major analyzers used for STD testing; %li%Profiles key suppliers and potential market entrants developing innovative technologies and products; and analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch's proprietary data files was conducted.
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests

1. AIDS: HIV/HIV-1/2/COMBO, HIVAG/HIV NAT,

Western Blot, HTLV-I/II

2. ADENOVIRUS

3. AEROMONAS

4. ANTHRAX/BACILLUS ANTHRACIS

5. ARBOVIRUSES

6. BABESIOSIS

7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)

and Other Bartonella (Rochalimaea)

8. BLASTOCYSTIS HOMINIS

9. BRUCELLA

10. CAMPYLOBACTER

11. CANDIDA

Table of Contents (continued)

12. CHAGAS DISEASE

13. CHANCROID

14. CHLAMYDIA

15. CLOSTRIDIUM DIFFICILE

16. CORONAVIRUSES

17. COXSACKIEVIRUSES

18. CREUTZFELDT-JAKOB’S DISEASE

19. CRYPTOSPORIDIUM PARVUM

20. CYCLOSPORA CAYETANENSIS

21. CYTOMEGALOVIRUS

22. EBOLA VIRUS

23. E. COLI

24. ECHOVIRUS

25. ENCEPHALITIS

26. ENTEROVIRUSES

27. EPSTEIN-BARR VIRUS

28. GIARDIA LAMBLIA

29. GONORRHEA

30. GRANULOMA INGUINALE

31. HANTAVIRUS

32. HELICOBACTER PYLORI

33. HEPATITIS: HAV NAT, HBV NAT, HBS AG, HCV, HCV NAT,

Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT

34. HERPES SIMPLEX VIRUS

35. HUMAN HERPES VIRUS-6 (HHV-6)

36. INFLUENZA VIRUSES

37. LEGIONELLA

38. LYME DISEASE

39. LYMPHOGRANULOMA VENEREUM (LGV)

40. MALARIA

41. MEASLES (RUBEOLA)

42. MENINGITIS

43. MICROSPORIDIUM

44. MONONUCLEOSIS

45. MUMPS

46. MYCOPLASMA

47. PAPILLOMAVIRUSES

48. PARVOVIRUS B19

49. PNEUMONIA

50. POLYOMAVIRUSES

51. PSEUDOMONAS AERUGINOSA

52. RABIES

53. RESPIRATORY SYNCYTIAL VIRUS (RSV)

54. RHINOVIRUSES

55. ROTAVIRUS


More Publications